Skip to content

Clinical trials

Acquired Immunodeficiency Syndrome trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Status: Unknown status Country / region: China Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20096
20122
20132
20141
20162
20172
20185
20195
20203
20213
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Public Health Clinical Center5
Peking Union Medical College Hospital4
First Affiliated Hospital of Zhejiang University3
Guang'anmen Hospital of China Academy of Chinese Medical Sciences3
Beijing 302 Hospital2
Centers for Disease Control and Prevention, China2
Guangzhou 8th People's Hospital2
National Center for AIDS/STD Control and Prevention, China CDC2
Sun Yat-sen University2
Central South University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome35
HIV Infections9
Cardiovascular Diseases2
Bone Diseases, Metabolic1
Hemophilia A1
Immune System Diseases1
Immunologic Deficiency Syndromes1
Lentivirus Infections1
Leukoencephalopathy, Progressive Multifocal1
Liver Diseases1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.